Sg3 Management, LLC Bria Cell Therapeutics Corp. Transaction History
Sg3 Management, LLC
- $0
- Q3 2023
A detailed history of Sg3 Management, LLC transactions in Bria Cell Therapeutics Corp. stock. As of the latest transaction made, Sg3 Management, LLC holds 50,000 shares of BCTX stock, worth $30,000. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$30,000% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCTX
# of Institutions
1Shares Held
1Call Options Held
0Put Options Held
0About BriaCell Therapeutics Corp.
- Ticker BCTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,518,000
- Market Cap $9.31M
- Description
- BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...